Taylor Sandison
2017
In 2017, Taylor Sandison earned a total compensation of $999.3K as Chief Medical Officer at Cidara Therapeutics, a 81% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $75,200 |
|---|---|
| Option Awards | $308,066 |
| Salary | $338,000 |
| Stock Awards | $278,000 |
| Total | $999,266 |
Sandison received $338K in salary, accounting for 34% of the total pay in 2017.
Sandison also received $75.2K in non-equity incentive plan, $308.1K in option awards and $278K in stock awards.
Rankings
In 2017, Taylor Sandison's compensation ranked 8,977th out of 14,666 executives tracked by ExecPay. In other words, Sandison earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,977 out of 14,666 | 39th |
Division Manufacturing | 3,435 out of 5,772 | 41st |
Major group Chemicals And Allied Products | 1,172 out of 2,075 | 44th |
Industry group Drugs | 936 out of 1,731 | 46th |
Industry Biological Products, Except Diagnostic Substances | 166 out of 313 | 47th |
Source: SEC filing on April 27, 2018.
Sandison's colleagues
We found three more compensation records of executives who worked with Taylor Sandison at Cidara Therapeutics in 2017.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019